Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

E-ISSN： 1527-6473|21|6|823-830

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.6, 2015-06, pp. : 823-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2442-2447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1105-1111

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1880-1886

John Wiley & Sons Inc

Access to resources Recommend Favorite

The corrected donor age for hepatitis C virus–infected liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1022-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite